Expression vector with CAG promoter, HA-tag, Neomycin selection.
Alternative name | pCAG-IN, stock no 1994 |
---|---|
Clone info. | Expression vector with CAG promoter, HA-tag, Neomycin selection. |
Vector backbone | pBRPyCAG-cHA-IN (Plasmid) |
Selectable markers | Amp^r (E. coli); neomycin (mammalian cells) |
Gene/insert name | cDNA |
Depositor|Developer | Niwa, Hitoshi | |
Sequence | RDB07105z.seq | Additional map | Remarks, protocol and/or map (pdf) | RDB07105p.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] For for-profit-research purpose, please contact us. |
---|---|
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Additional terms and conditions: Regarding resources containing CAG promoter: In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation for the CAG promoter (Niwa, H., Yamamura, K., Miyazaki, J., Gene 108 : 193-200, 1991) is requested. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。営利目的利用についてはお問い合わせください。 |
---|---|
MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する。 MTAに書く付加的使用条件: CAGプロモータを含むリソースについて: 利用者は、研究成果の公表にあたってCAGプロモータの文献 (Niwa, H., Yamamura, K., Miyazaki, J., Gene 108 : 193-200, 1991)を引用を必要とする。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07105 | pBRPyCAG-cHA-IN | DNA solution |
Materials & Methods section:
The pBRPyCAG-cHA-IN was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07105). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB10973_A4L1p1-2.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: pAxCA_F1 () Sequence file: RDB10973_A4L1a.seq |
---|
>07105_10973_A4L1_2_pAxCA_F1_A02_02.ab1 1 CATTGAGCAC GGCGGGGGTT CTCTGCTACA TGTTTCTTGC CTTCTTCTTT TTCCTACAGC 61 CTCCTGGGCA ACGTGCTGGT TATTGTGCTG TCTCATCATT TTGGCAAAGA ATTCCTCGAG 121 ATCTCACGCG TGACTAGTGC CATGGCCTAC CCATACGACG TGCCAGACTA CGCCTAGCGG 181 CCGCTCGATA AGCTTGATAT CGAATTCCGC CCCCCCCCCC TCTCCCT // |
Primer: IRES-F () Sequence file: RDB10973_A4L1b.seq |
>07105_10973_A4L1_2_IRES-F_B02_05.ab1 1 GCCTGTCCCT TAAATGTGTT TTAGGTCGGA GGTTAAAAAA ACGTCTAGGC CCCCCGAACC 61 ACGGGGACGT GGTTTTCCTT TGAAAAACAC GATGATAATA TGGCCACAAC CATGATTGAA 121 CAAGATGGAT TGCACGCAGG TTCTCCGGCC GCTTGGGTGG AGAGGCTATT CGGCTATGAC 181 TGGGCACAAC AGACAATCGG CTGCTCTGAT GCCGCCGTGT TCCGGCTGTC AGCGCAGGGG 241 CGCCCGGTTC TTTTTGTCAA GACCGACCTG TCCGGTGCCC TGAATGAACT GCAGGACGAG 301 GCAGCGCGGC TATCGTGGCT GGCCACGACG GGCGTTCCTT GCGCAGCTGT GCTCGACGTT 361 GTCACTGAAG CGGGAAGGGA CTGGCTGCTA TTGGGCGAAG TGCCGGGGCA GGATCTCCTG 421 TCATCTCACC TTGCTCCTGC CGAGAAAGTA TCCATCATGG CTGATGCAAT GCGGCGGCTG 481 CATACGCTTG ATCCGGCTAC CTGCCCATTC GACCACCAAG CGAAACATCG CATCGAGCGA 541 GCACGTACTC GGATGGAAGC CGGTCTTGTC GATCAGGATG ATCTGGACGA AGAGCATCAG 601 GGGCTCGCGC CAGCCGAACT GTTCGCCAGG CTCAAGGCGC GCATGCCCGA CGGCGAGGAT 661 CTCGTCGTGA CCCATGGCGA TGCCTGCTTG CCGAATATCA TGGTGGAAAA TGGCCGCTTT 721 TCTGGATTCA TCGACTGTGG CCGGCTGGGT GTGGCGGACC GCTATCAGGA CATAGCGTTG 781 GCTACCCGTG ATATTGCTGA AGAGCTTGGC GGCGAATGGG CTGACCGCTT CCTCGTGCTT 841 TACGGTATCG CCGCTCCCGA TTCGCAGCGC ATCGCCTTCT ATCGCCTTCT TGACGAGTTC 901 TTCTGAGGGG ATCGGCAATA AAAAGACAGA ATAAAACGCA CGGGTGTTGG GTCGTTTGTT 961 CGGATCCCAC GGGTGCGCAT GATTCGTGCT CCCTGTCGTT GAGGACCCGG GCTAGGCTGG 1021 CGGGGGGTTG CCCTTACTGG GTTTAGCAGA ATGAATCACC GATACGCGAG CGAACGTGAA 1081 AGCGACTGCC TGCTGCAAAA CGTCTGCCGA ACCTGAACAA CCACAATGAA TGATCTTCCG 1141 GGATTACGTT GTATTTCCGT AAAGTTTCTT GGAAACACGG CGGGAAAAGT TTCTCAGGTA 1201 G // |
Primer: SV40pA3ElementReverse () Sequence file: RDB10973_A4L1c.seq |
>07105_10973_A4L1_2_SV40pA3ElementReverse_C02_08.ab1 1 GACGTCGGGG GGGGGGCGGA GCCTATGGAA AACGCCAGCA ACGCGGCCTT TTTACGGTTC 61 CTGGCCTTTT GCTGGCCTTT TGCTCACATG TTCTTTCCTG CGTTATCCCC TGATTCTGTG 121 GATAACCGTA TTACCGCCTT TGAGTGAGCT GATACCGCTC GCCGCAGCCG AACGACCGAG 181 CGCAGCGAGT CAGTGAGCGA GGAAGCGGAA GAGCGCCTGA TGCGGTATTT TCTCCTTACG 241 CATCTGTGCG GTATTTCACA CCGCATATGG TGCACTCTCA GTACAATCTG CTCTGATGCC 301 GCATAGTTAA GCCAGTATAC ACTCCGCTAT CGCTACGTGA CTGGGTCATG GCTGCGCCCC 361 GACACCCGCC AACACCCGCT GACGCGCCCT GACGGGCTTG TCTGCTCCCG GCATCCGCTT 421 ACAGACAAGC TGTGACCGTC TCCGGGAGCT GCATGTGTCA GAGGTTTTCA CCGTCATCAC 481 CGAAACGCGC GAGGCAGCTG CGGTAAAGCT CATCAGCGTG GTCGTGAAGC GATTCACAGA 541 TGTCTGCCTG TTCATCCGCG TCCAGCTCGT TGAGTTTCTC CAGAAGCGTT AATGTCTGGC 601 TTCTGATAAA GCGGGCCATG TTAAGGGCGG TTTTTTCCTG TTTGGTCACT GATGCCTCCG 661 TGTAAGGGGG ATTTCTGTTC ATGGGGGTAA TGATACCGAT GAAACGAGAG AGGATGCTCA 721 CGATACGGGT TACTGATGAT GAACATGCCC GGTTACTGGA ACGTTGTGAG GGTAAACAAC 781 TGGCGGTATG GATGCGGCGG GACCAGAGAA AAATCACTCA GGGTCAATGC CAGCGCTTCG 841 TTAATACAGA TGTAGGTGTT CCACAGGGTA GCCAGCAGCA TCCTGCGATG CAGATCCGGA 901 ACATAATGGT GCAGGGCGCT GACTTCCGCG TTTCCAGACT TTACGAAACA CGGAAACCGA 961 AGACCATTCA TGTTGTTGCT CAAGGTCGCA GACGTTTTGC AGCAGCAGTC GCTTCACGTT 1021 CGCTCGCGTA TCGGGTGATT CATTTCTGCT AACCAGTAAA GGCAACCCCG CCCAGCCCTA 1081 GCCCGGTTCC TCAACGACAA GGGAGCACGG AATCATGCGC AACCGTTGGA TCCCTAAACA 1141 AAACGAACCC AACCACCCCG CGGTGCGCGG TGT // |
Primer: Amp_R () Sequence file: RDB10973_A4L1d.seq |
>07105_10973_A4L1_2_Amp_R_E09_15.ab1 1 ATGTCGTTTT TATGACCGCT TTGGAAAACA AAGACTGTAT TTCCTGGAAA TTAATGTTTA 61 TTCAATAAAC TGTGTATTCA GCTATATTCA CATAGTGGTG AGGCTGAAAT GAGGCGGGAA 121 GAGGCGGTTG GGGCTTAATT ATATCAATTT GGGTGGCCCC ACAGCGCCTC CAAGGCGCCA 181 GTCCTGTTTT GACAAGTTGC CTCTGGAAGC CTCTCTTCTT TTTCTCCAGA GTAAGCGGAG 241 GCCAGGGGCC CCCGGCCTCT GCTTAATACT AAAAAAAACA GCTGTTGTCA TAGTAATGAT 301 TGGGTGGAAA CATTCCAGGC CTGGGTGGAG AGGCTTTTTG CTTCCTCTTG CAAAACCACA 361 CTGACATTCC AGGCCTGGGT GGAGAGGCTT TTTGCTTCCT CTTGCAAAAC CACACTGCCC 421 TCTGGAGGGC AGTTGCCTAG CAACTAATTA AAAGAGGATG TCGCACGGCC AGCTGCGGTC 481 AGTTAGTCAC TTCCTGCTTA ACTGACTTGA CATTTTCTAT TTTAAGAGTC GGGAGGAAAA 541 TTACTGTGTT GGAGGCCCTC CGCCATCTTC TGAAGCTGAA TCGAATTAAC TTGTTTATTG 601 CAGCTTATAA TGGTTACAAA TAAAGCAATA GCATCACAAA TTTCACAAAT AAAGCATTTT 661 TTTCACTGCA TTCTAGTTGT GGTTTGTCCA AACTCATCAA TGTATCTTAT CATGTCTGGA 721 TCTGATATCA TCGTCGACAT TGATTATTGA CTAGCTAGTT ATTAATAGTA ATCAATTACG 781 GGGTCATTAG TTCATAGCCC ATATATGGAG TTCCGCGTTA CATAACTTAC GGTAAATGGC 841 CCGCCTGGCT GACCGCCCAA CGACCCCCGC CCATTGACGT CAATAATGAC GTATGTTCCC 901 ATAGTAACGC CAATAGGGAC TTTCCATTGA CGTCAATGGG TGGAGTATTT ACGGTAAACT 961 GCCCACTTGG CAGTACATCA AGTGTATCAT ATGCCAAGTA CGCCCCCTAT TGACGTCAAT 1021 GACGGTAAAT GGCCCGCCTG GCATTATGCC CAGTACATGA CCCTTATGGG ACTTTCCTAC 1081 TTGGGCAGTA CATCTACGTA TTAGTCATCG CTATTACCAT GATGTCGAAG TTGAGCCCAC 1141 GTCCTGCCTC CACTCTCCCC ATTCTTCCCC CCCCCTTTCC CCAAAGGC // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content